At a glance
ClinicalIndex Comparison RecordN/ACompleted· 8 enrolled
Drug / intervention
Hydrochlorothiazidedrug
Likely dose
Hydrochlorothiazide 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Translational Approach to Gitelman Syndrome
In Brief
A clinical study evaluating Hydrochlorothiazide for Gitelman Syndrome. Completed, enrolled 8 participants across 1 site.
Detailed Summary
This study will test the response to a single dose of thiazide diuretic as a diagnostic test for Gitelman syndrome. Individuals with hypokalemic alkalosis will be enrolled. After a baseline study, they will have the response to 50 mg hydrochlorothiazide on fractional chloride excretion examined.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGitelman Syndrome
CountriesUnited States
CollaboratorsOregon Clinical and Translational Research Institute
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
First PostedJan 2009
Primary CompletionJan 2013
Study CompletionSep 2013
TodayJul 2026
First PostedJan 14, 2009
Enrollment StartJan 1, 2009
Primary CompletionJan 1, 2013
Study CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 17.5 years ago
Interventions
Hydrochlorothiazidedrug
50 mg one time